CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan Bayer AG - BAYN CFD

56.85
1.34%
0.15
Rendah: 56.5
Tinggi: 57
Market Trading Hours* (UTC) Open now
Closes on Tuesday at 16:30

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.15
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.017913 %
Charges from borrowed part ($-0.72)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.017913%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.004309 %
Charges from borrowed part ($-0.17)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.004309%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang EUR
Margin 20%
Bursa efek Germany
Komisi perdagangan 0%

*Information provided by Capital.com

Bayer AG ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Key Stats
Prev. Close* 56.1
Open* 56.5
1-Year Change* -2.33%
Day's Range* 56.5 - 57
52 wk Range 46.70-67.99
Average Volume (10 days) 2.86M
Average Volume (3 months) 56.95M
Market Cap 55.05B
P/E Ratio 13.26
Shares Outstanding 982.42M
Revenue 50.74B
EPS 4.22
Dividend (Yield %) 4.28342
Beta 1.21
Next Earnings Date May 11, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 20, 2023 56.10 0.40 0.72% 55.70 56.45 54.80
Mar 17, 2023 56.00 0.05 0.09% 55.95 56.85 55.45
Mar 16, 2023 55.95 -0.45 -0.80% 56.40 56.75 55.10
Mar 15, 2023 55.75 -0.30 -0.54% 56.05 57.55 55.65
Mar 14, 2023 57.15 0.80 1.42% 56.35 57.70 55.90
Mar 13, 2023 56.15 -1.35 -2.35% 57.50 57.55 56.05
Mar 10, 2023 57.50 0.20 0.35% 57.30 57.80 56.75
Mar 9, 2023 58.10 0.00 0.00% 58.10 58.40 57.95
Mar 8, 2023 58.45 1.00 1.74% 57.45 58.70 57.45
Mar 7, 2023 57.20 -0.40 -0.69% 57.60 58.00 57.10
Mar 6, 2023 57.50 0.15 0.26% 57.35 57.75 57.25
Mar 3, 2023 57.55 0.70 1.23% 56.85 57.65 56.85
Mar 2, 2023 56.70 1.05 1.89% 55.65 56.85 55.60
Mar 1, 2023 56.15 -0.20 -0.35% 56.35 56.65 55.75
Feb 28, 2023 56.35 -0.10 -0.18% 56.45 57.40 55.30
Feb 27, 2023 58.60 -0.60 -1.01% 59.20 59.35 58.60
Feb 24, 2023 59.10 -0.85 -1.42% 59.95 60.20 58.95
Feb 23, 2023 60.00 1.15 1.95% 58.85 60.20 58.85
Feb 22, 2023 58.85 0.00 0.00% 58.85 59.00 58.45
Feb 21, 2023 59.20 0.05 0.08% 59.15 59.60 58.70

Bayer AG Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 34943 35015 36742 43545 41400 44081
Revenue 34943 35015 36742 43545 41400 44081
Cost of Revenue, Total 11756 11382 15381 17613 19138 16816
Gross Profit 23187 23633 21361 25932 22262 27265
Total Operating Expense 29205 29112 33288 39383 57569 40728
Selling/General/Admin. Expenses, Total 13097 13258 14881 16156 15980 15370
Research & Development 4405 4504 5105 5301 7126 5412
Interest Expense (Income) - Net Operating -120 -33 -4 183 -54 42
Unusual Expense (Income) 217 124 -3600 315 15345 3484
Other Operating Expenses, Total -150 -123 1525 -185 34 -396
Operating Income 5738 5903 3454 4162 -16169 3353
Interest Income (Expense), Net Non-Operating -631 -761 -1239 -1052 -976 -1317
Other, Net -334 -565 -329 -257 -105 10
Net Income Before Taxes 4773 4577 1886 2853 -17250 2046
Net Income After Taxes 3756 3248 1390 2410 -15561 1022
Minority Interest -13 1 -16 -19 -8 -22
Net Income Before Extra. Items 3743 3249 1374 2391 -15569 1000
Total Extraordinary Items 788 4087 321 1700 5074 0
Net Income 4531 7336 1695 4091 -10495 1000
Income Available to Common Excl. Extra. Items 3743 3249 1374 2391 -15569 1000
Income Available to Common Incl. Extra. Items 4531 7336 1695 4091 -10495 1000
Diluted Net Income 4531 7336 1695 4091 -10495 1000
Diluted Weighted Average Shares 845.953 885.187 940.76 981.69 982.42 982.42
Diluted EPS Excluding Extraordinary Items 4.42459 3.67041 1.46052 2.4356 -15.8476 1.01789
Dividends per Share - Common Stock Primary Issue 2.65707 2.75548 2.8 2.8 2 2
Diluted Normalized EPS 5.43668 4.65407 3.46921 3.32619 -1.24738 2.44155
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 12328 10854 9781 11118 14639
Revenue 12328 10854 9781 11118 14639
Cost of Revenue, Total 4698 4546 3887 3685 5176
Gross Profit 7630 6308 5894 7433 9463
Total Operating Expense 9245 13135 9251 9097 10427
Selling/General/Admin. Expenses, Total 3521 3747 3766 4291 3945
Research & Development 1198 1638 1564 1012 1454
Other Operating Expenses, Total -172 3204 34 109 -148
Operating Income 3083 -2281 530 2021 4212
Interest Income (Expense), Net Non-Operating -348 -99 -336 -524 -490
Net Income Before Taxes 2735 -2380 194 1497 3722
Net Income After Taxes 2090 -2328 90 1170 3294
Minority Interest -1 -7 -5 -9 -3
Net Income Before Extra. Items 2089 -2335 85 1161 3291
Total Extraordinary Items 0 0 0 0
Net Income 2089 -2335 85 1161 3291
Income Available to Common Excl. Extra. Items 2089 -2335 85 1161 3291
Income Available to Common Incl. Extra. Items 2089 -2335 85 1161 3291
Diluted Net Income 2089 -2335 85 1161 3291
Diluted Weighted Average Shares 980.751 982.42 982.42 982.42 982.388
Diluted EPS Excluding Extraordinary Items 2.13 -2.37678 0.08652 1.18178 3.35
Dividends per Share - Common Stock Primary Issue 0 0 0 2 0
Diluted Normalized EPS 2.11831 0.22078 0.41188 2.33293 3.31397
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 30447 30073 31065 32439 35675 32578
Cash and Short Term Investments 5424 9098 5002 5404 11883 7739
Cash & Equivalents 1899 7581 4052 3185 4191 4564
Short Term Investments 3525 1517 950 2219 7692 3175
Total Receivables, Net 14734 11031 14137 14851 12157 12980
Accounts Receivable - Trade, Net 10969 8582 11714 11678 9552 10047
Total Inventory 8408 6550 11132 10650 10961 11314
Prepaid Expenses 1208 804 344 290 314 307
Other Current Assets, Total 673 2590 450 1244 360 238
Total Assets 82238 75087 126732 126174 116804 120241
Property/Plant/Equipment, Total - Net 13114 7633 12943 12479 11723 12688
Property/Plant/Equipment, Total - Gross 35529 18836 25458 24380 23646 26188
Accumulated Depreciation, Total -22415 -11203 -12515 -11901 -11923 -13500
Goodwill, Net 16312 14751 38442 39126 36418 40106
Intangibles, Net 13567 11674 36696 34709 25424 26258
Long Term Investments 1753 5273 1586 971 993 1195
Note Receivable - Long Term 409 475 1500 1501 1506 2005
Other Long Term Assets, Total 6636 5208 4500 4949 5065 5411
Total Current Liabilities 18537 13593 23125 23215 36768 29403
Accounts Payable 6410 5129 6038 6426 5678 6792
Accrued Expenses 1084 164 367 343 374 339
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2889 1050 2958 1975 8359 3053
Other Current Liabilities, Total 8154 7250 13762 14471 22357 19219
Total Liabilities 51905 38286 80755 78921 86281 87221
Total Long Term Debt 15375 12158 37708 36907 33198 36478
Long Term Debt 14998 11952 37359 35955 32267 35549
Capital Lease Obligations 377 206 349 952 931 929
Deferred Income Tax 1330 1153 4667 3755 1175 931
Minority Interest 1564 60 171 180 152 148
Other Liabilities, Total 15099 11322 15084 14864 14988 20261
Total Equity 30333 36801 45977 47253 30523 33020
Common Stock 2117 2117 2387 2515 2515 2515
Additional Paid-In Capital 9658 9658 18388 18261 18261 18261
Retained Earnings (Accumulated Deficit) 18558 25026 25739 26151 13059 13345
Total Liabilities & Shareholders’ Equity 82238 75087 126732 126174 116804 120241
Total Common Shares Outstanding 840.309 840.309 932.552 982.424 982.424 982.424
Unrealized Gain (Loss) 122 310 117 212
Other Equity, Total -659 16 -3429 -1313
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 35814 32451 31945 32578 38246
Cash and Short Term Investments 9312 6498 8219 7906 8194
Cash & Equivalents 5550 3389 4316 4564 5785
Short Term Investments 3762 3109 3903 3342 2409
Total Receivables, Net 15910 15796 13052 13282 17824
Accounts Receivable - Trade, Net 12969 13075 10048 10047 14601
Total Inventory 10457 10125 10644 11314 10869
Other Current Assets, Total 135 32 30 76 1359
Total Assets 118528 114427 116549 120241 125782
Property/Plant/Equipment, Total - Net 11823 11830 12036 12688 12786
Goodwill, Net 37580 36965 39421 40106 39789
Intangibles, Net 25798 25308 24970 26258 26066
Long Term Investments 2242 2201 2279 2655 2677
Note Receivable - Long Term 1049 1199 1289 1376 1323
Other Long Term Assets, Total 4222 4473 4609 4580 4895
Total Current Liabilities 28977 27926 28727 29403 31019
Accounts Payable 5185 5118 5587 6792 5847
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4946 3708 4792 4391 5899
Other Current Liabilities, Total 18846 19100 18348 18220 19273
Total Liabilities 83939 84038 85446 87221 88345
Total Long Term Debt 37923 36664 36974 36481 36648
Long Term Debt 37923 36664 36974 36481 36648
Deferred Income Tax 1207 840 740 931 926
Minority Interest 161 189 170 148 170
Other Liabilities, Total 15671 18419 18835 20258 19582
Total Equity 34589 30389 31103 33020 37437
Common Stock 2515 2515 2515 2515 2515
Additional Paid-In Capital 18261 18261 18261 18261 18261
Retained Earnings (Accumulated Deficit) 13813 9613 10327 12244 16661
Total Liabilities & Shareholders’ Equity 118528 114427 116549 120241 125782
Total Common Shares Outstanding 982.424 982.424 982.424 982.424 982.424
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 4558 3248 1390 2430 -15561 1022
Cash From Operating Activities 9092 8134 7918 8187 4896 5128
Cash From Operating Activities 3743 2660 6241 5365 13259 3056
Non-Cash Items 1656 2489 -2580 899 1198 795
Cash Taxes Paid 2092 1821 2028 2561 1063 2159
Cash Interest Paid 853 801 1331 1517 1301 1227
Changes in Working Capital -865 -263 2867 -507 6000 255
Cash From Investing Activities -8729 -432 -34152 -671 -4073 855
Capital Expenditures -2578 -2366 -2593 -2650 -2418 -2611
Other Investing Cash Flow Items, Total -6151 1934 -31559 1979 -1655 3466
Cash From Financing Activities -350 -1881 23432 -8389 423 -5645
Financing Cash Flow Items -794 -755 -966 -1478 -1276 -1200
Total Cash Dividends Paid -2126 -2364 -2407 -2615 -2768 -1993
Issuance (Retirement) of Stock, Net 3300 3717 8986 0
Issuance (Retirement) of Debt, Net -730 -2479 17819 -4296 4467 -2452
Foreign Exchange Effects 27 -139 -581 6 -240 35
Net Change in Cash 40 5682 -3383 -867 1006 373
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 2090 -238 -148 1022 3294
Cash From Operating Activities -2765 -768 2091 5128 -723
Cash From Operating Activities 1086 2476 3346 3056 1080
Non-Cash Items 218 143 382 795 376
Cash Taxes Paid 453 1140 1666 2159 442
Cash Interest Paid 156 547 800 1227 173
Changes in Working Capital -6159 -3149 -1489 255 -5473
Cash From Investing Activities 3945 4392 1843 855 742
Capital Expenditures -329 -822 -1471 -2611 -349
Other Investing Cash Flow Items, Total 4274 5214 3314 3466 1091
Cash From Financing Activities 113 -4490 -3847 -5645 1075
Financing Cash Flow Items -142 -525 -778 -1200 -137
Issuance (Retirement) of Debt, Net 255 -2000 -1100 -2452 1197
Foreign Exchange Effects 66 64 38 35 132
Net Change in Cash 1359 -802 125 373 1226
Total Cash Dividends Paid -1965 -1969 -1993
Issuance (Retirement) of Stock, Net 15
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.56 64447020 4034208 2022-09-21 LOW
MFS Investment Management Investment Advisor/Hedge Fund 3.0361 29826993 463404 2022-07-05 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 3.0056 29527878 2387504 2023-01-13 LOW
Harris Associates L.P. Investment Advisor/Hedge Fund 2.986 29334705 -298339 2022-03-28 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8778 28272478 52992 2023-02-28 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.6294 16007791 450013 2023-02-28 LOW
Dodge & Cox Investment Advisor/Hedge Fund 1.5093 14827876 -16000 2022-12-31 LOW
Capital Research Global Investors Investment Advisor 1.4893 14631293 23538 2023-02-28 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 1.1404 11203658 3336785 2023-02-28 HIGH
Union Investment Privatfonds GmbH Investment Advisor 1.13 11101531 0 2022-12-31 LOW
Nuveen LLC Pension Fund 1.017 9991315 -5792 2023-02-28 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 0.9122 8961477 431215 2023-02-28 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.8788 8633158 -4791 2023-01-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.8166 8022517 -335076 2023-02-28 LOW
Invesco Advisers, Inc. Investment Advisor 0.8143 7999997 -2019 2023-01-31 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 0.7335 7206563 176584 2023-02-28 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6744 6625102 6577 2023-02-28 LOW
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.6542 6427484 -26965 2023-01-31 LOW
Goldman Sachs Asset Management, L.P. Investment Advisor 0.5548 5450773 -76579 2022-12-19 LOW
Newton Investment Management Ltd. Investment Advisor 0.5213 5121067 457742 2023-01-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
500000+

Trader

92000+

Klien aktif per bulan

$53000000+

Volume investasi per bulan

$30000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Pharmaceuticals (NEC)

Kaiser-Wilhelm-Allee 1
LEVERKUSEN
NORDRHEIN-WESTFALEN 51373
DE

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,579.70 Price
+0.150% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

BTC/USD

27,760.95 Price
-1.200% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Gold

1,966.46 Price
-0.670% 1D Chg, %
Biaya inap posisi Long -0.0172%
Biaya inap posisi short 0.0089%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

XRP/USD

0.39 Price
+2.380% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00420

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda